187 related articles for article (PubMed ID: 31149200)
1. MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).
Gheorghisan-Galateanu AA; Terzea D; Valea A; Carsote M
Acta Endocrinol (Buchar); 2017; 13(3):356-363. PubMed ID: 31149200
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
4. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
5. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
6. Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report.
Vatopoulou A; Gkrozou F; Birbas E; Kanavos T; Skentou C; Miliaras D
Case Rep Womens Health; 2023 Sep; 39():e00537. PubMed ID: 37692362
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal Hyperandrogenism Associated With Synchronous Ovarian Brenner Tumor, Bilateral Leydig Cell Tumor, and Adrenal Mass.
Salim M; Dasaraju S; Erickson B; Khalifa M; Burmeister LA
Cureus; 2024 Mar; 16(3):e55334. PubMed ID: 38559537
[TBL] [Abstract][Full Text] [Related]
8. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
Fanta M; Fischerová D; Indrielle-Kelly T; Koliba P; Zdeňková A; Burgetová A; Vrbíková J
J Obstet Gynaecol; 2019 Apr; 39(3):359-364. PubMed ID: 30428740
[TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Hyperandrogenism Due to Fibrothecoma and Leydig Cell Tumor in a Postmenopausal Woman With Adrenal Adenoma: A Case Report and Literature Review.
Hussain A; Uy E; Marlowe S; Piercy J; Akbar A
Cureus; 2023 Aug; 15(8):e43180. PubMed ID: 37692722
[TBL] [Abstract][Full Text] [Related]
12. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
13. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
Palha A; Cortez L; Tavares AP; Agapito A
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
[TBL] [Abstract][Full Text] [Related]
14. Hyperandrogenism due to ovarian Leydig cell tumour presenting with polycythaemia.
Demir AY; Blok BB; Brinkhuis EA; Oldenburg-Ligtenberg CP
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35840164
[TBL] [Abstract][Full Text] [Related]
15. The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report.
Suturina LV; Sharifulin EM; Sharifulin MA; Lazareva LM; Danusevich IN; Ievleva KD; Nadeliaeva IG
Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888744
[TBL] [Abstract][Full Text] [Related]
16. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women.
Bahaeldein E; Brassill MJ
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153
[TBL] [Abstract][Full Text] [Related]
17. Bilateral Leydig Cell Hyperplasia: A Rare Cause of Postmenopausal Hirsutism.
Pathmanathan S; De Silva SDN; Sumanatilleke M; Lokuhetty D; Ranathunga UVV
Case Rep Endocrinol; 2022; 2022():8804856. PubMed ID: 35190778
[TBL] [Abstract][Full Text] [Related]
18. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
[TBL] [Abstract][Full Text] [Related]
19. [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].
Marcelino M; Nobre E; Conceição J; Lopes L; Vilar H; França Martins M; Carvalho A; André S; Horta A; De Castro JJ
Acta Med Port; 2010; 23(1):113-8. PubMed ID: 20353714
[TBL] [Abstract][Full Text] [Related]
20. Marked hyperandrogenicity in a 60-year-old woman.
Aljenaee K; Ali S; Cheah SK; MacEneaney O; Mulligan N; Hickey N; Tun TK; Sreenan S; McDermott JH
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28924479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
